Internal Medicine, Gastroenterology · Loveland, CO
NPI
1265415459
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2555 E 13th St, Suite 220
Loveland, CO, 80537
Phone (970) 669-5432
Groups this clinician bills Medicare through
Medicare paid, 2024
$309K
11,850 services
Medicare patients, 2024
683
Average age 75
Drug cost, 2024
$1.3M
4,552 prescriptions
Company payments, 2024
$53.21
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lewis R Strong was code J3380 (injection, vedolizumab, intravenous, 1 mg), 6,000 times for 14 patients. In total Lewis R Strong billed 11,850 services in 63 codes, and Medicare paid $309K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 6,000 | 14 | $17.38 | $104K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,160 | 15 | $25.00 | $29K |
| 88305 Surgical Pathology Examination | Office | 677 | 348 | $25.43 | $17K |
| 45385 Colonoscopy - Lesion Removal | Facility | 204 | 203 | $203.99 | $42K |
| 43239 Upper GI Endoscopy | Facility | 172 | 169 | $58.28 | $10K |
| 99213 Office E&M - Established | Office | 164 | 138 | $67.76 | $11K |
| 45380 Lower GI Endoscopy - Other | Facility | 158 | 158 | $84.06 | $13K |
| 88312 Surgical Pathology Examination | Office | 61 | 61 | $65.74 | $4,010 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 55 | 55 | $179.89 | $9,894 |
| 96413 Chemotherapy Administration | Office | 48 | 30 | $98.79 | $4,742 |
| 43249 Upper GI Endoscopy | Facility | 43 | 37 | $96.04 | $4,130 |
| 99214 Office E&M - Established | Office | 41 | 40 | $100.64 | $4,126 |
| 99222 Hospital E&M - Initial | Facility | 33 | 31 | $102.45 | $3,381 |
| 99232 Hospital E&M - Subsequent | Facility | 32 | 21 | $61.71 | $1,975 |
| 43248 Upper GI Endoscopy | Facility | 29 | 29 | $101.25 | $2,936 |
By year: 2022 $333K for 14,953 services; 2023 $389K for 17,730 services; 2024 $309K for 11,850 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 677 | 348 | $25.43 | $17K |
| 88312 Surgical Pathology Examination | 61 | 61 | $65.74 | $4,010 |
| 88313 Surgical Pathology Examination | 29 | 28 | $55.23 | $1,602 |
Medicare prescription drug claims, 2024
In 2024, the drug Lewis R Strong prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 1,697 prescriptions and refills. In total Lewis R Strong wrote 4,552 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 1,697 | 1,709 | 1,680 | $112K |
| Ondansetron Hcl Generic | 1,537 | 1,537 | 1,516 | $2,839 |
| Omeprazole Generic | 408 | 1,158 | 143 | $5,398 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 211 | 211 | 208 | $3,845 |
| Suprep Sodium, Potassium,mag Sulfates | 162 | 173 | 162 | $14K |
| Ondansetron Odt Ondansetron | 97 | 97 | 93 | $1,016 |
| Budesonide Dr Budesonide | 57 | 69 | 19 | $7,626 |
| Mesalamine Generic | 43 | 131 | 12 | $17K |
| Stelara Ustekinumab | 37 | 47 | Under 11 | $1.0M |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 30 | 30 | 29 | $674 |
| Cholestyramine Cholestyramine (With Sugar) | 28 | 50 | Under 11 | $2,184 |
| Ursodiol Generic | 27 | 61 | Under 11 | $9,298 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 25 | 25 | 25 | $460 |
| Lansoprazole Generic | 22 | 68 | Under 11 | $696 |
| Sandostatin Lar Depot Octreotide Acetate,mi-Spheres | 13 | 13 | Under 11 | $56K |
Brand drugs: 760 claims; generic drugs: 3,792 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Lewis R Strong $53.21 ($53.21 in general payments such as food, travel and fees) from 2 companies. The largest payer was Echosens North America, Inc. with $28.17.
| Company | Payments | Amount |
|---|---|---|
| Echosens North America, Inc. | 1 | $28.17 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $25.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.